Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TELA - TELA Bio Inc


IEX Last Trade
2.91
-0.020   -0.687%

Share volume: 28,422
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$2.93
-0.02
-0.68%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-2.03%
1 Month
-34.54%
3 Months
-48.40%
6 Months
-57.04%
1 Year
-70.01%
2 Year
-65.88%
Key data
Stock price
$2.91
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$2.54 - $9.60
52 WEEK CHANGE
-$0.70
MARKET CAP 
71.670 M
YIELD 
N/A
SHARES OUTSTANDING 
24.714 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
0.46
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$97,042
AVERAGE 30 VOLUME 
$236,994
Company detail
CEO:
Region: US
Website: telabio.com
Employees: 205
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

tela bio, inc., a surgical reconstruction company, was created out of the desire to do things differently. combining the drive and innovation of a start-up with a seasoned medical technology team, the company aims to commercialize a portfolio of products that are purposefully designed to address a range of unmet needs in soft tissue repair. based in malvern, pennsylvania, this science-driven company is collaborating with leading surgeons to reinvigorate the soft tissue reconstruction market and bring cost-effective solutions to hospitals, surgeons and patients. please see our social media community guidelines at http://bit.ly/1uvcx0l

Recent news